1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderEnrolling by invitationPhase 32025-07-20NCT05127954